Intersect Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $3M | Sell |
32,949
-554
| -2% | -$49.1K | 0.91% | 20 |
|
|
2022
Q1 | $2.75M | Buy |
33,503
+415
| +1% | +$32.7K | 0.53% | 38 |
|
|
2021
Q4 | $2.54M | Sell |
33,088
-19,541
| -37% | -$1.56M | 0.47% | 43 |
|
|
2021
Q3 | $3.95M | Sell |
52,629
-711
| -1% | -$54.1K | 0.68% | 26 |
|
|
2021
Q2 | $4.15M | Sell |
53,340
-4,103
| -7% | -$305K | 0.73% | 23 |
|
|
2021
Q1 | $4.22M | Sell |
57,443
-2,515
| -4% | -$186K | 0.86% | 20 |
|
|
2020
Q4 | $4.68M | Buy |
59,958
+740
| +1% | +$56.6K | 1.03% | 18 |
|
|
2020
Q3 | $4.69M | Buy |
59,218
+156
| +0.3% | +$12.2K | 1.26% | 16 |
|
|
2020
Q2 | $4.36M | Buy |
59,062
+2,841
| +5% | +$214K | 1.41% | 15 |
|
|
2020
Q1 | $4.13M | Sell |
56,221
-363
| -0.6% | -$28.5K | 1.64% | 13 |
|
|
2019
Q4 | $4.91M | Buy |
56,584
+763
| +1% | +$62.7K | 1.64% | 13 |
|
|
2019
Q3 | $4.48M | Buy |
55,821
+942
| +2% | +$75.5K | 1.67% | 13 |
|
|
2019
Q2 | $4.39M | Buy |
54,879
+707
| +1% | +$54.1K | 1.7% | 12 |
|
|
2019
Q1 | $4.3M | Buy |
54,172
+133
| +0.2% | +$9.95K | 1.81% | 11 |
|
|
2018
Q4 | $3.94M | Sell |
54,039
-823
| -2% | -$58.1K | 1.89% | 12 |
|
|
2018
Q3 | $3.71M | Buy |
54,862
+701
| +1% | +$44.7K | 1.62% | 14 |
|
|
2018
Q2 | $3.14M | Sell |
54,161
-1,508
| -3% | -$85.1K | 1.51% | 15 |
|
|
2018
Q1 | $2.89M | Sell |
55,669
-4,019
| -7% | -$217K | 1.53% | 17 |
|
|
2017
Q4 | $3.21M | Sell |
59,688
-4,215
| -7% | -$234K | 1.73% | 16 |
|
|
2017
Q3 | $3.9M | Buy |
63,903
+176
| +0.3% | +$10.7K | 2.22% | 11 |
|
|
2017
Q2 | $3.9M | Buy |
63,727
+18,580
| +41% | +$1.13M | 2.34% | 12 |
|
|
2017
Q1 | $2.74M | Sell |
45,147
-9,963
| -18% | -$604K | 2.38% | 13 |
|
|
2016
Q4 | $3.1M | Sell |
55,110
-2,295
| -4% | -$134K | 2.32% | 12 |
|
|
2016
Q3 | $3.42M | Sell |
57,405
-19,980
| -26% | -$1.17M | 2.7% | 10 |
|
|
2016
Q2 | $4.25M | Buy |
77,385
+7,217
| +10% | +$384K | 2.56% | 10 |
|
|
2016
Q1 | $3.54M | Buy |
70,168
+17,803
| +34% | +$872K | 2.23% | 11 |
|
|
2015
Q4 | $2.64M | Buy |
52,365
+2,204
| +4% | +$111K | 2.27% | 11 |
|
|
2015
Q3 | $2.36M | Sell |
50,161
-2,188
| -4% | -$116K | 2.17% | 10 |
|
|
2015
Q2 | $2.84M | Sell |
52,349
-602
| -1% | -$33.8K | 2.41% | 10 |
|
|
2015
Q1 | $3.01M | Buy |
52,951
+4,308
| +9% | +$244K | 2.31% | 10 |
|
|
2014
Q4 | $2.64M | Buy |
+48,643
| New | +$2.71M | 2.21% | 10 |
|
Other funds holding MRK
Intersect Capital's MRK Position: Q2 2022 in Review
Intersect Capital reduced its Merck (MRK) stake by 1.7% in Q2 2022, selling an estimated $49.1K and leaving 32,949 shares worth $3M. The position accounts for 0.91% of the portfolio, ranked #20.
Intersect Capital first reported a position in MRK in Q4 2014 and has held it in 31 quarters since. The position peaked at $4.91M in Q4 2019. 3,014 funds tracked by Wall St. Rank hold MRK as of Q2 2022.
- Intersect Capital held 32,949 shares of Merck worth $3M as of Q2 2022.
- Intersect Capital sold 554 Merck shares in Q2 2022, an estimated $49.1K.
- Merck made up 0.91% of Intersect Capital's portfolio in Q2 2022, its #20 holding.
- Intersect Capital first reported a position in Merck in Q4 2014 and has held it in 31 quarters since.
- Intersect Capital's Merck position peaked at $4.91M in Q4 2019.
- 3,014 funds tracked by Wall St. Rank held Merck as of Q2 2022.
Based on Intersect Capital's 13F filing for Q2 2022, filed 2 Sep 2022.